DaShenLin Pharmaceutical Group Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100002RG2
CNY
17.92
-0.1 (-0.55%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
26,377.78
24,436.71
21,168.14
16,691.21
14,522.83
11,080.06
8,797.58
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
26,377.78
24,436.71
21,168.14
16,691.21
14,522.83
11,080.06
8,797.58
Raw Material Cost
17,950.22
16,186.83
13,646.40
10,735.17
9,285.54
6,904.63
5,397.16
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
282.33
275.34
270.69
238.48
38.48
55.33
47.58
Selling and Distribution Expenses
6,906.05
6,379.17
5,875.75
4,833.54
3,869.84
3,261.75
2,679.06
Other Expenses
-23.29
-19.90
-19.85
-19.59
-3.47
-5.51
-4.71
Total Expenditure (Excl Depreciation)
24,905.67
22,642.34
19,594.30
15,611.28
13,159.19
10,166.57
8,076.72
Operating Profit (PBDIT) excl Other Income
1472.1000000000001
1794.4
1573.8
1079.8999999999999
1363.6000000000001
913.5
720.9000000000001
Other Income
105.34
110.45
117.98
149.88
123.14
59.39
43.07
Operating Profit (PBDIT)
3,530.00
3,584.93
3,226.59
2,614.47
1,822.59
1,267.40
995.01
Interest
282.33
275.34
270.69
238.48
38.48
55.33
47.58
Exceptional Items
-13.10
14.22
-9.10
35.32
2.79
-0.03
10.30
Gross Profit (PBDT)
8,427.56
8,249.88
7,521.73
5,956.04
5,237.28
4,175.43
3,400.42
Depreciation
1,894.89
1,695.89
1,531.87
1,367.26
339.80
292.45
237.73
Profit Before Tax
1,339.67
1,627.93
1,414.94
1,044.04
1,447.10
919.59
720.00
Tax
359.73
397.12
335.62
239.52
363.39
222.95
193.87
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
914.75
1,166.50
1,035.72
791.23
1,062.18
702.66
531.63
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
914.75
1,166.50
1,035.72
791.23
1,062.18
702.66
531.63
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
65.19
64.16
43.55
13.16
20.84
-6.12
-5.95
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
979.94
1,230.66
1,079.27
804.39
1,083.02
696.54
525.69
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
6,897.24
6,823.85
6,211.88
5,478.58
5,179.35
4,239.90
3,038.11
Earnings per share (EPS)
0.81
1.03
0.91
0.7
0.94
0.53
0.49
Diluted Earnings per share
0.81
1.03
0.91
0.7
0.94
0.53
0.49
Operating Profit Margin (Excl OI)
5.8%
7.28%
7.45%
6.57%
9.36%
8.26%
8.12%
Gross Profit Margin
12.26%
13.6%
13.92%
14.45%
12.3%
10.94%
10.89%
PAT Margin
3.47%
4.77%
4.89%
4.74%
7.31%
6.34%
6.04%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 7.94% vs 15.44% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is -20.38% vs 14.03% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is -1.43% vs 11.77% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 2.54% vs 1.70% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has fallen from Dec 2023

Compare Annual Results Of DaShenLin Pharmaceutical Group Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
26,377.78
0
26,377.78
Other Operating Income
0.00
0.00
0.00
Total Operating income
26,377.78
0
26,377.78
Raw Material Cost
17,950.22
0
17,950.22
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
282.33
0
282.33
Selling and Distribution Expenses
6,906.05
0
6,906.05
Other Expenses
-23.29
0.00
-23.29
Total Expenditure (Excl Depreciation)
24,905.67
0
24,905.67
Operating Profit (PBDIT) excl Other Income
1,472.11
0.00
1,472.11
Other Income
105.34
0
105.34
Operating Profit (PBDIT)
3,530.00
0
3,530.00
Interest
282.33
0
282.33
Exceptional Items
-13.10
0
-13.10
Gross Profit (PBDT)
8,427.56
0
8,427.56
Depreciation
1,894.89
0
1,894.89
Profit Before Tax
1,339.67
0
1,339.67
Tax
359.73
0
359.73
Provisions and contingencies
0
0
0.00
Profit After Tax
914.75
0
914.75
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
914.75
0
914.75
Share in Profit of Associates
0
0
0.00
Minority Interest
65.19
0
65.19
Other related items
0.00
0.00
0.00
Consolidated Net Profit
979.94
0
979.94
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
6,897.24
0
6,897.24
Earnings per share (EPS)
0.81
0
0.81
Diluted Earnings per share
0.81
0
0.81
Operating Profit Margin (Excl OI)
5.80%
0%
0.00
5.80%
Gross Profit Margin
12.26%
0%
0.00
12.26%
PAT Margin
3.47%
0%
0.00
3.47%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 2,637.78 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 7.94% vs 15.44% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 97.99 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -20.38% vs 14.03% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 342.47 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -1.43% vs 11.77% in Dec 2023

Annual - Interest
Interest 28.23 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 2.54% vs 1.70% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 5.80%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has fallen from Dec 2023